SESSION 1
Thursday, February 22, 2024
8:00am
Moderator:
Mo Banki, MD, DMD, Chair
Keynote Speaker:
Lydia A. Bazzano, MD, PhD, MPH
Summary:
This talk will explore the evolving landscape of weight loss interventions and examine promising advancements that will shape the future of obesity treatment.
Discover how semaglutide and similar innovative treatments, originally developed for managing diabetes, are reshaping the landscape of aesthetic enhancements through weight loss stimulation. Learn the key management principles when considering these medications in your practice
Session Details:
Welcome
Mo Banki, MD, DMD, FACS, Chair
President’s Address
Alex Sobel, DO, FAACS
Housekeeping Notes
Victoria Ceh, MPA
Keynote Speaker Introduction
Mo Banki, MD, DMD, FACS
The Future of Weight Loss: The GLP-1 Agonist Revolution
Lydia A. Bazzano, MD, PhD, MPH
Q&A